By
AmyT on
November 12, 2008
While we’re on the topic of diabetes technologies and advancements this week, I’d like to share what I’ve learned about two more companies working on some alluring diabetes innovations.
DiaSome Pharmaceuticals, located in Conshohoken, PA, is developing a “proprietary nanotechnology cell-receptor targeting system” designed to deliver insulin to the hepatocyte cells in the liver via both oral and injectable drug routes. According to their documentation, “the site-specific targetting of insulin essentially restores ‘normal physiology’ to…
Read more »
By
AmyT on
November 12, 2008
While we’re on the topic of diabetes technologies and advancements this week, I’d like to share what I’ve learned about two more companies working on some alluring diabetes innovations.
DiaSome Pharmaceuticals, located in Conshohoken, PA, is developing a “proprietary nanotechnology cell-receptor targeting system” designed to deliver insulin to the hepatocyte cells in the liver via both oral and injectable drug routes. According to their documentation, “the site-specific targetting of insulin essentially restores ‘normal physiology’ to…
Read more »
By
AmyT on
November 10, 2008
On Wednesday of this week, the eighth annual Diabetes Technology Meeting convenes in Bethesda, MD, for a three-day event (spanning this year’s World Diabetes Day on Thursday) that will survey the latest technological advances for people with diabetes. How I’d love to be a fly on the wall at that conference!
Nevermind that I’ve been trying to gain press access to this meeting for at least the last 3 years; I have a mole this…
Read more »
By
AmyT on
October 6, 2008
iPod, iPhone, iPump, iPort, iV-drip (?)… so no reason to look surprised when you hear about another futuristic diabetes technology company by the name of iSense.
This one, a privately held company based in Oregon, has been working on developing a “minimally invasive” continuous glucose monitoring system (CGMS) for about ten years. (I’m guessing the company name sounded a lot more futuristic back then.)
From what I gather, what’s new and different with the iSense…
Read more »
By
AmyT on
September 18, 2008
If you don’t know about Kelly Close and her work in the diabetes industry, you’re definitely missing out. She’s a Type 1 herself, a former Wall St. analyst, smart as a whip, and just about the sweetest person you could ever hope to admire.
A Guest Post by Kelly Close, diabetes industry consultant
We recall our grandparents talking about their first experience watching “moving pictures” — for that generation, a revolutionary development from still photographs.…
Read more »
